FDA converts lecanemab to traditional approval
Lecanemab represents the first antibody treatment for Alzheimer’s disease to have received traditional approval from the Food and Drug Administration in the US.
Lecanemab represents the first antibody treatment for Alzheimer’s disease to have received traditional approval from the Food and Drug Administration in the US.
In partnership with ITN Productions, ADI has released the documentary film ‘Every 3 seconds’ to help raise awareness on the global impact of dementia.
As 2021 comes to an end, ADI CEO Paola Barbarino reflects on the work of ADI in 2021 and what we are looking towards to in 2022.
ADI calls for lived experience to be central to innovation in the field of dementia diagnostics, treatment and care. In her short interview with Novartis, Paola Barbarino highlights key areas which innovators must consider when developing their products and service, from inception, to testing and ultimately bringing them to market; and reminds us not to forget that simple innovative changes can lead to great impact.
Alzheimer’s Disease International (ADI) and partner Dementia Alliance International (DAI) join other civil society organisations in a statement to the World Health Organization (WHO).
ADI's vision, mission and values define what we do. We have a 3 year strategic plan which guides our work.
ADI's history from its foundation in 1984 to the present. How ADI has grown to be the worldwide federation of over 100 Alzheimer associations.
Her Majesty Queen Silvia of Sweden has become an Honorary Ambassador of Alzheimer’s Disease International (ADI), in recognition of her personal commitment to work surrounding elderly and end of life care, and specifically dementia. Queen Silvia has a long-standing association with and in support of dementia. In 1996, she initiated…
This webinar focuses on the clinical trial data for Biogen’s investigational drug aducanumab. If approved, aducanumab would be the first disease-modifying treatment for Alzheimer’s disease.
ADI hosted its first virtual regional meeting for ADI members in Latin America, since the COVID-19 pandemic began, on 12 November. The second virtual regional meeting Asia Pacific took place a week later on 12 November. During the Latin America meeting, 18 participants from 13 countries were in attendance. The 2-hour meeting…